MODULATION OF TRANSTHYRETIN EXPRESSION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240132885A1
SERIAL NO

18060965

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods, compounds, and compositions for reducing expression of transthyretin mRNA and protein in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate transthyretin amyloidosis, or a symptom thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IONIS PHARMACEUTICALS INCCALIFORNIA USA CALIFORNIA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Freier, Susan M San Diego, US 526 6555
Guo, Shuling Carlsbad, US 33 56
Monia, Brett P Encinitas, US 303 5836
Siwkowski, Andrew M Carlsbad, US 55 1386

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation